HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kawashima, H. Articles by Strobel, H. W. Search for Related Content PubMed PubMed Citation Articles by Kawashima, H. Articles by Strobel, H. W. Social Bookmarking                      What's this?

Volume 271, Number 45, Issue of November 8, 1996 pp. 28176-28180
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Genomic Cloning and Protein Expression of a Novel Rat Brain Cytochrome P-450 CYP2D18* Catalyzing Imipramine N-Demethylation

(Received for publication, February 7, 1996, and in revised form, August 21, 1996)

Hidenori Kawashima , David J. Sequeira , David R. Nelson ^§ and Henry W. Strobel

From the  Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, Texas 77225 and the ^§ Department of Biochemistry, University of Tennessee at Memphis, Memphis, Tennessee 38163

We have previously reported the isolation of two cDNA clones, designated 2d-29 and 2d-35, which have identical open reading frames and code for a novel brain cytochrome P-450 (P-450) belonging to the CYP2D subfamily, and noted that the mRNA of clone 2d-35 seems to be expressed in the brain but not in the liver (). Although the deduced amino acid sequence of these clones differs from that of the liver CYP2D4 by only 5 amino acids distributed in the C-terminal region, this new P-450 cDNA clone contained a unique 5-extension, and we posit in this report by analysis of a genomic clone that this 5-untranslated sequence is derived from a gene distinct from that of CYP2D4. Thus, this novel P-450 was named P-450 2D18 according to the recommended nomenclature (). The expressibility of this cDNA was confirmed by in vitro translation using a reticulocyte system, and protein expression was performed using COS-M6 cells. Immunoblot analysis showed a cross-reacting band of the predicted size range with anti-P-450 2D6 antiserum, which was not seen in control cells. Furthermore, the CYP2D18-expressed COS cell lysate showed N-demethylation activity toward imipramine, whereas another brain P-450 CYP4F6-expressed COS cell lysate showed 10-hydroxylation activity. This is the first report that associates an individual P-450 isozyme in brain with a particular metabolic alteration of the antidepressant imipramine.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?